Results 111 to 120 of about 40,872 (293)

Cardiovascular disease incidence and cancer risk in two large European prospective cohorts

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Cardiovascular disease (CVD) and cancer share risk factors and biological mechanisms, raising questions about potential associations between the two, particularly regarding CVD duration and cancer onset. Whether CVD influences subsequent cancer risk, however, remains inconclusive.
Emma Fontvieille   +25 more
wiley   +1 more source

Experience in the treatment of gastric fistulas associated with combat abdominal trauma

open access: yesZaporožskij Medicinskij Žurnal
External gastric fistulas have always been a complication of gastric surgery. Russia’s full-scale invasion of Ukraine has led to an increase in the number of wounded patients presenting with this pathology.
O. M. Biesiedin   +2 more
doaj   +1 more source

The Endothelial CXCR Family in Vascular Health and Disease

open access: yesiNew Medicine, EarlyView.
ABSTRACT Endothelial cells (ECs) form the dynamic interface between blood and tissue, serving as key regulators of vascular homeostasis, inflammation, and repair. Among the molecular systems governing endothelial behavior, the C‐X‐C motif chemokine receptor (CXCR) family—originally characterized in immunology for its roles in leukocyte trafficking and ...
Zhiming Wu   +4 more
wiley   +1 more source

Hypertrophic pyloric stenosis [PDF]

open access: yes, 2013
A 6-week old baby was brought to A&E by her parents, after a 3 week history of frequent vomiting, not tolerating feeds, and weight loss. She was well for the first 3 weeks of life, before she stopped tolerating any feeds. Despite several changes with the
Tabone, Trevor   +1 more
core  

Critical Appraisal of Pancreaticogastrostomy After Pancreatoduodenectomy: Evolution, Evidence, and Future Prospects

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Pancreaticogastrostomy (PG) emerged as a reconstructive option after pancreaticoduodenectomy (PD) due to its reported lower incidence of postoperative pancreatic fistula (POPF), but its superiority over pancreaticojejunostomy (PJ) remains unclear.
Samuel Menezes   +4 more
wiley   +1 more source

A case report of Peutz–Jeghers syndrome in a child with Crohn's disease

open access: yesJPGN Reports, EarlyView.
Abstract Peutz–Jeghers syndrome (PJS) is a rare genetic disorder characterized by hamartomatous polyps and mucocutaneous hyperpigmented freckles, whereas Crohn's disease (CD) is a condition characterized by chronic intestinal inflammation. Here, we present a rare case report of an 11‐year‐old male who presented with both CD and PJS.
Hasala Rannulu   +5 more
wiley   +1 more source

Postoperative Weight Gain, Due to Fluid Retention After Ovarian Cancer Surgery—How Much Is too Much?

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Postoperative complications after cytoreductive surgery in ovarian cancer patients are associated with impaired survival. Here, we investigated the association between postoperative weight gain due to fluid retention and the development of complications and anastomotic leakage (AL).
Eva K. Egger   +7 more
wiley   +1 more source

Spontaneous Gastrosplenic Fistula Resulting From Primary Gastric Lymphoma: Case Report and Review of the Literature

open access: yesBalkan Medical Journal, 2011
A fistulous tract between the stomach and the spleen is a rare manifestation. Spontaneous gastrosplenic fistula formation resulting from primary gastric lymphoma is extremely rare and should be managed as an emergency.
Münevver Moran   +5 more
doaj  

Duodenal diversion surgery in management of intractable tracheobroncho-gastric fistula after esophagectomy. [PDF]

open access: yesGen Thorac Cardiovasc Surg Cases, 2023
Urabe M   +6 more
europepmc   +1 more source

Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial. [PDF]

open access: yes, 2019
BackgroundThe AspireAssist is the first Food and Drug Administration-approved endoluminal device indicated for treatment of class II and III obesity.ObjectivesWe earlier reported 1-year results of the PATHWAY study.
Abu Dayyeh, Barham K   +27 more
core  

Home - About - Disclaimer - Privacy